EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Stuck Between a Rock and a Hard Place: Anticoagulation in End-Stage Kidney Disease Patients With Atrial Fibrillation

Samuel Sherng Young Wang, Devanshi Patidar, Keerthana Mallavarapu, Xiao Ran Luo, Rajiva G Ibakkanavar, Muhammad Masoom Javaid

British Journal of Hospital Medicine · 2026

DOI: 10.31083/bjhm51833 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Hospital Medicine, 2026. Verfasst von Samuel Sherng Young Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Medicine Academic Programme, SingHealth, 168582 Singapore, Singapore. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Kidney Failure, Chronic, Stroke. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anticoagulation using vitamin K antagonists or direct oral anticoagulants is an established treatment option for stroke prevention in patients with atrial fibrillation (AF). Although AF is common in patients with end-stage kidney disease (ESKD), the role of anticoagulation in stroke prevention has not been established in this group of patients. Major clinical trials have excluded patients with advanced kidney disease and this explains the significant lack of evidence-based guidelines to aid clinical decisions in the management of AF in patients with ESKD. Results from smaller studies and meta-analyses involving ESKD patients have not shown any significant advantage of using anticoagulants in preventing thromboembolic events. Moreover, anticoagulation has been associated with a higher risk of significant bleeding in dialysis patients. Therefore, caution and individualised treatment plans are suggested when considering ESKD patients’ anticoagulation. Ongoing clinical trials might illuminate this situation and help formulate more definitive guidance for anticoagulation use in ESKD patients. In summary, insufficient and inconclusive data, which results in the lack of evidence-based guidelines and the unique hemostatic paradox intrinsic to ESKD, muddle the management of AF in ESKD. This underscores the need to consolidate and synthesize data from past and ongoing studies to compare existing treatment options and identify gaps in knowledge that can direct further studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAnticoagulantsKidney Failure, ChronicStrokeHumansThromboembolismHemorrhage

Stichwörter der Autor:innen

anticoagulationatrial fibrillationdirect oral anticoagulantsend-stage kidney diseasestrokethromboembolismwarfarin

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Medicine, Medicine Academic Programme, SingHealth, 168582 Singapore, Singapore.
  • Department of Medicine, Duke-NUS Medical School, 169857 Singapore, Singapore.
  • Department of Renal Medicine, Woodlands Health, 737628 Singapore, Singapore.
  • Monash Rural Health Mildura, Monash University, Mildura, VIC 3500, Australia.
  • Department of Medicine, South West Healthcare, Warrnambool, VIC 3280, Australia.
  • Deakin Medical School, Deakin University, Warrnambool, VIC 3280, Australia.

Zitieren

APA

Wang, S. S. Y., Patidar, D., Mallavarapu, K., Luo, X. R., Ibakkanavar, R. G., & Javaid, M. M. (2026). Stuck Between a Rock and a Hard Place: Anticoagulation in End-Stage Kidney Disease Patients With Atrial Fibrillation. British Journal of Hospital Medicine. https://doi.org/10.31083/bjhm51833

Vancouver

Wang SSY, Patidar D, Mallavarapu K, Luo XR, Ibakkanavar RG, Javaid MM. Stuck Between a Rock and a Hard Place: Anticoagulation in End-Stage Kidney Disease Patients With Atrial Fibrillation. British Journal of Hospital Medicine. 2026. doi:10.31083/bjhm51833

BibTeX
@article{Wang2026,
  author = {Wang, Samuel Sherng Young and Patidar, Devanshi and Mallavarapu, Keerthana and Luo, Xiao Ran and Ibakkanavar, Rajiva G and Javaid, Muhammad Masoom},
  title = {Stuck Between a Rock and a Hard Place: Anticoagulation in End-Stage Kidney Disease Patients With Atrial Fibrillation},
  journal = {British Journal of Hospital Medicine},
  year = {2026},
  doi = {10.31083/bjhm51833}
}
Kostenlos starten →